Premium
Unifarm SA Company has concluded a framework contract with a producer in South Korea for the acquisition of 2,000,000 molecular diagnostic tests (Real Time Polymerase Chain Reaction - PCR), the Strategic Communication Group (GCS) informed on Sunday.
"We mention that in this period, Unifarm SA Company is constantly seeking to obtain, from authorized manufacturers around the world, diagnostic tests, other devices, but also medicines necessary to limit the spreading of COVID-19, which it distributes to sanitary units or medical offices, order-based," the same source mentions.
